Hypertensive retinopathy in a rat model: modulation by an endothelin-receptor antagonist

被引：0
|
作者：
de Gooyer, TE
McDonald, L
McDonald, D
Lee, GR
Canning, P
Kelso, EJ
McDermott, BJ
Stitt, AW
机构：
[1] Queens Univ Belfast, Ophthalm Res Ctr, Belfast BT7 1NN, Antrim, North Ireland
[2] Queens Univ Belfast, Cardiovasc Res Ctr, Belfast BT7 1NN, Antrim, North Ireland
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2004年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3256
引用
收藏
页码：U94 / U94
页数：1
相关论文
共 50 条
  • [41] Endothelin-receptor antagonist FR 139317 reduces infarct size in a rabbit model when given before, but not after, coronary artery occlusion
    Burke, SE
    Nelson, RA
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1997, 29 (01) : 87 - 92
  • [42] Endothelin antagonist in experimental diabetic retinopathy
    不详
    [J]. DIABETES OBESITY & METABOLISM, 2000, 2 (04): : 257 - 258
  • [43] Effects in renal and cardiac tissue from CKD rat model: antioxidant evaluation of treatment with the selective endothelin-receptor antagonist atrasentan and the combination of atrasentan with the vitamin D receptor activator (paricalcitol), and the angiot
    Munoz, Kevin
    Slatopolsky, Eduardo
    Zhang, Sarah
    Finch, Jane
    Liapis, Helen
    Delmez, James
    Ritter, Cindy
    Ferder, Leon
    Suarez, Edu
    [J]. FASEB JOURNAL, 2014, 28 (01):
  • [44] The future of endothelin-receptor antagonism as treatment for systemic hypertension
    Vorobiof, Gabriel
    Blaxall, Burns C.
    Bisognano, John D.
    [J]. CURRENT HYPERTENSION REPORTS, 2006, 8 (01) : 35 - 44
  • [45] Endothelin-receptor antagonists in arterial hypertension: Further indications?
    Sudano, Isabella
    Hermann, Matthias
    Ruschitzka, Frank T.
    [J]. CURRENT HYPERTENSION REPORTS, 2007, 9 (01) : 59 - 65
  • [46] Endothelin-receptor antagonists in arterial hypertension: Further indications?
    Isabella Sudano
    Matthias Hermann
    Frank T. Ruschitzka
    [J]. Current Hypertension Reports, 2007, 9
  • [47] The future of endothelin-receptor antagonism as treatment for systemic hypertension
    Gabriel Vorobiof
    Burns C. Blaxall
    John D. Bisognano
    [J]. Current Hypertension Reports, 2006, 8 : 35 - 44
  • [48] Endothelin-receptor antagonists: Heart failure drugs of the future?
    Fricker, J
    [J]. LANCET, 1996, 348 (9041): : 1573 - 1573
  • [49] Intravitreal administration of endothelin type A receptor or endothelin type B receptor antagonists attenuates hypertensive and diabetic retinopathy in rats
    Alrashdi, Saeed F.
    Deliyanti, Devy
    Wilkinson-Berka, Jennifer L.
    [J]. EXPERIMENTAL EYE RESEARCH, 2018, 176 : 1 - 9
  • [50] Endothelin receptor antagonist
    Lloyd, AW
    [J]. DRUG DISCOVERY TODAY, 1997, 2 (12) : 554 - 554
12345